Form 10-Q HOOKIPA Pharma Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
HOOKIPA Pharma Inc. (HOOK) PT Lowered to $48 at RBC Capital
November 15, 2024 6:32 AM ESTRBC Capital analyst Brian Abrahams lowered the price target on HOOKIPA Pharma Inc. (NASDAQ: HOOK) to $48.00 (from $50.00) while maintaining a Outperform rating.
The analyst comments "With enrollment wrapped up in the ph.II portion of the ongoing OL study... More
